| Value | ₹80.00 Cr |
|---|
BSE filing, NSE: BARODARAYN. Summary written from the filing by ALFA Finder's alert engine.
Baroda Rayon Corporation Ltd: key numbers
- Share price
- ₹127.80
- Market cap
- ₹292.8 Cr
- Revenue (annual)
- ₹61.77 Cr
- Net profit (annual)
- ₹22.21 Cr
- P/E (TTM)
- 8.7×Sector 50.0×
- Promoter holding
- 67.53%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Baroda Rayon Corporation Ltd
All →Baroda Rayon Corporation Board Meeting Date
Baroda Rayon scheduled its Board of Directors meeting for 6 Nov 2026 to review standalone unaudited results for Q1 and H1 FY27. Trading window remains closed until 48 hours after result declaration.
Baroda Rayon Corporation Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Baroda Rayon Corporation Other Announcement
The company submitted a NIL report regarding physical share transfer requests re-lodged under the SEBI-mandated special window for the month of September 2026.
Baroda Rayon Corporation Annual General Meeting
The company announced the voting results of its 66th Annual General Meeting held on September 29, 2026. All resolutions were passed by the requisite majority.
Baroda Rayon Corporation Annual General Meeting
The Baroda Rayon Corporation Limited held its 66th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of FY26 financial statements and director re-appointments.
Baroda Rayon Corporation Other Announcement
The Company submitted a NIL report regarding physical share transfer requests re-lodged under the special window for August 2026.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr